Chiron Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$349K Sell
902
-600
-40% -$223K 0.31% 78
2026
Q1
$440K Buy
+1,502
New +$494K 0.45% 57
2025
Q3
$679K Buy
+2,102
New +$654K 0.58% 52
2020
Q4
Sell
-200
Closed -$54K 180
2020
Q3
$54K Buy
+200
New +$53.8K 0.04% 146

Other funds holding ELV

Chiron Capital Management's ELV Position: Q2 2026 in Review

Chiron Capital Management reduced its Elevance Health (ELV) stake by 40% in Q2 2026, selling an estimated $223K and leaving 902 shares worth $349K. The position accounts for 0.31% of the portfolio, ranked #78.

Chiron Capital Management first reported a position in ELV in Q3 2020 and has held it in 4 quarters since. The position peaked at $679K in Q3 2025. 304 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Chiron Capital Management held 902 shares of Elevance Health worth $349K as of Q2 2026.
  • Chiron Capital Management sold 600 Elevance Health shares in Q2 2026, an estimated $223K.
  • Elevance Health made up 0.31% of Chiron Capital Management's portfolio in Q2 2026, its #78 holding.
  • Chiron Capital Management first reported a position in Elevance Health in Q3 2020 and has held it in 4 quarters since.
  • Chiron Capital Management's Elevance Health position peaked at $679K in Q3 2025.
  • 304 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.